Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Prokaryotics, Inc. in August, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI145409-02 | Phase II | 1,000,000 | August 16, 2021 | |||||||
A SBIR Phase II contract was awarded to Prokaryotics, Inc. in July, 2019 for $952,958.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI138688-02 | Phase II | 952,958 | July 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Prokaryotics, Inc. in August, 2019 for $295,541.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI145409-01 | Phase I | 295,541 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Prokaryotics, Inc. in June, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI138688-01A1 | Phase I | 300,000 | June 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Prokaryotics, Inc. in September, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI165008-01A1 | Phase I | 300,000 | September 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Prokaryotics, Inc. in July, 2022 for $999,396.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI136213-04 | Phase II | 999,396 | July 8, 2022 | |||||||
A SBIR Phase II contract was awarded to Prokaryotics, Inc. in December, 2018 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI136213-02 | Phase II | 1,000,000 | December 24, 2018 | |||||||
A SBIR Phase I contract was awarded to Prokaryotics, Inc. in February, 2018 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI136213-01 | Phase I | 299,999 | February 5, 2018 | |||||||
A STTR Phase I contract was awarded to Prokaryotics, Inc. in August, 2023 for $299,326.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AI179344-01 | Phase I | 299,326 | August 15, 2023 |